The FTD SARS-CoV-2/FluA/FluB/HRSV assay is used for executing the detection of five respiratory viruses from one sample eluate, including SARS-CoV-2, Influenza A virus, Influenza B virus, and human Respiratory Syncytial Viruses A/B.

A new analysis verifies Siemens Healthineers PCR influenza assays to detect new H3N2 influenza strains displaying genetic drifts.

The influenza A assay contained in the FTD SARS-CoV-2/FluA/FluB/HRSV Assay*, FTD Respiratory pathogens 21 Assay*, and FTD FLU/HRSV Assay* helps detect the new H3N2 strain displaying genetic drifts.

The FTD™ SARS-CoV-2/FluA/FluB/HRSV Assay, for use on the VERSANT® kPCR Molecular System, is a semi-automated reverse-transcription real-time PCR assay for in-vitro qualitative detection and variation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; ORF1ab and N genes), influenza B virus (IBV), influenza A virus (IAV), and human respiratory syncytial virus A and B (HRSV A/B) RNA in nasopharyngeal swab specimens in a viral transport medium acquired from individuals with symptoms and signs of respiratory infections.

The test helps diagnose SARS-CoV-2, IBV, IAV, and HRSV A/B in humans.

Clinical use

Respiratory testing

At the time of the COVID-19 pandemic, the circulation of respiratory viruses altered considerably, and recent flu seasons have displayed atypical patterns compared to pre-pandemic times. The upcoming seasons are anticipated to return to normal with the co-circulation of respiratory viruses.

The epithelial cells of the respiratory tract have been targeted by SARS-CoV-2 and cause an infection that could result in Coronavirus disease 2019 (COVID-19). Influenza A and B are significant causes of seasonal respiratory infections in adults and children with a quick onset of fever.

HRSV is a significant cause of severe lower respiratory tract infections in children, immuno-compromised patients, and the aged. It is the primary viral cause of death in infants below one year of age.

The new RT-PCR FTD SARS-CoV-2/FluA/FluB/HRSV Assay from Siemens Healthineers detects such five comparative pathogens to fulfill users’ laboratory’s clinical and epidemiological (surveillance) requirements.

Emergent SARS-CoV-2 variants

Being part of the Global Surveillance Program, the FTD SARS-CoV-2 Assay and FTD SARS-CoV-2/FluA/ HRSV/FluB Assay have detected emergent SARS-CoV-2 variants.

New analysis with FTD SARS-CoV-2/FluA/FluB/HRSV Assay

Image Credit: Siemens Healthineers

Features and benefits

  • Detection of SARS-CoV-2, Influenza B virus, Influenza A virus, and human Respiratory Syncytial Viruses A and B from the similar sample eluate
  • Differentiation happening between SARS-CoV-2, FluA, FluB, and HRSV A/B
  • Developed with the same high SARS-CoV-2 sensitivity as the FTD SARS-CoV-2 Assay (targets conserved regions within ORF1ab and N gene)
  • Mid- to high-throughput semi-automated solution to control seasonal respiratory testing in the context of the COVID-19 pandemic and beyond

Other Equipment by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.